GYPA |
P02724
|
glycophorin A (MNS blood group)
|
|
1.1E-03 |
0.538 |
0.885 |
HLA-DRB1 |
P01911
|
major histocompatibility complex, class II, DR beta 1
|
Immune response
|
1.1E-03 |
0.333 |
0.923 |
HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
NFE2L2 |
Q16236
|
nuclear factor, erythroid 2 like 2
|
Enzyme
|
3.6E-03 |
0.357 |
0.885 |
GYPE |
P15421
|
glycophorin E (MNS blood group)
|
|
3.7E-03 |
0.578 |
0.808 |
IL10 |
P22301
|
interleukin 10
|
|
5.9E-03 |
0.281 |
0.923 |
CXCR4 |
P61073
|
C-X-C motif chemokine receptor 4
|
G-protein coupled receptor
|
1.8E-02 |
0.362 |
0.923 |
CAP1 |
Q01518
|
cyclase associated actin cytoskeleton regulatory protein 1
|
Cellular structure
|
2.0E-02 |
0.529 |
0.808 |
CCR2 |
P41597
|
C-C motif chemokine receptor 2
|
|
2.3E-02 |
0.418 |
0.846 |
HLA-DQA1 |
P01909
|
major histocompatibility complex, class II, DQ alpha 1
|
Immune response
|
2.4E-02 |
0.416 |
0.846 |
THBD |
P07204
|
thrombomodulin
|
|
5.4E-02 |
0.457 |
0.769 |
IL1B |
P01584
|
interleukin 1 beta
|
|
0.13 |
0.276 |
0.962 |
THPO |
P40225
|
thrombopoietin
|
|
0.20 |
0.513 |
0.692 |
IL6 |
P05231
|
interleukin 6
|
|
0.32 |
0.248 |
0.962 |
CXCL10 |
P02778
|
C-X-C motif chemokine ligand 10
|
Signaling
|
0.37 |
0.378 |
0.885 |
CSF3 |
P09919
|
colony stimulating factor 3
|
|
0.38 |
0.377 |
0.885 |
IFNG |
P01579
|
interferon gamma
|
|
0.47 |
0.288 |
0.962 |
IL2 |
P60568
|
interleukin 2
|
|
0.48 |
0.336 |
0.885 |
NRAS |
P01111
|
NRAS proto-oncogene, GTPase
|
Enzyme modulator
|
0.49 |
0.390 |
0.808 |
CD59 |
P13987
|
CD59 molecule (CD59 blood group)
|
|
0.61 |
0.469 |
0.808 |
CCL2 |
P13500
|
C-C motif chemokine ligand 2
|
Signaling
|
0.61 |
0.321 |
0.962 |
TNF |
P01375
|
tumor necrosis factor
|
Signaling
|
0.80 |
0.231 |
0.962 |
FAS |
P25445
|
Fas cell surface death receptor
|
|
0.81 |
0.372 |
0.923 |
CSF2 |
P04141
|
colony stimulating factor 2
|
Signaling
|
0.83 |
0.330 |
0.962 |
PIGA |
P37287
|
phosphatidylinositol glycan anchor biosynthesis class A
|
|
0.96 |
0.575 |
0.654 |